Your browser doesn't support javascript.
loading
Quantitative 31P-NMR for Purity Determination of Sofosbuvir and Method Validation.
Uchiyama, Nahoko; Kiyota, Kohei; Hosoe, Junko; Komatsu, Takanori; Sugimoto, Naoki; Ishizuki, Kyoko; Koide, Tatsuo; Murabayashi, Mika; Kobayashi, Kengo; Fujimine, Yoshinori; Yokose, Toshiyuki; Ofuji, Katsuya; Shimizu, Hitoshi; Hasebe, Takashi; Asai, Yumi; Ena, Eri; Kikuchi, Junko; Fujita, Kazuhiro; Makino, Yoshinobu; Iwamoto, Yoshiaki; Miura, Toru; Muto, Yasuhiro; Asakura, Katsuo; Suematsu, Takako; Muto, Hitomi; Kohama, Ai; Goto, Takashi; Yasuda, Masu; Ueda, Tomohiko; Goda, Yukihiro.
Afiliação
  • Uchiyama N; National Institute of Health Sciences (NIHS).
  • Kiyota K; SHIONOGI & Co., Ltd.
  • Hosoe J; National Institute of Health Sciences (NIHS).
  • Komatsu T; JEOL RESONANCE Inc.
  • Sugimoto N; National Institute of Health Sciences (NIHS).
  • Ishizuki K; National Institute of Health Sciences (NIHS).
  • Koide T; National Institute of Health Sciences (NIHS).
  • Murabayashi M; Takeda Pharmaceutical Co., Ltd.
  • Kobayashi K; Daiichi Sankyo Co., Ltd.
  • Fujimine Y; Otsuka Pharmaceutical Co., Ltd.
  • Yokose T; Otsuka Pharmaceutical Co., Ltd.
  • Ofuji K; Chugai Pharmaceutical Co., Ltd.
  • Shimizu H; Chugai Pharmaceutical Co., Ltd.
  • Hasebe T; Eisai Co., Ltd.
  • Asai Y; Eisai Co., Ltd.
  • Ena E; Eisai Co., Ltd.
  • Kikuchi J; SHIONOGI & Co., Ltd.
  • Fujita K; SHIONOGI & Co., Ltd.
  • Makino Y; Juzen Chemical Corp.
  • Iwamoto Y; FUJIFILM Wako Pure Chemical Corporation.
  • Miura T; FUJIFILM Wako Pure Chemical Corporation.
  • Muto Y; FUJIFILM Wako Pure Chemical Corporation.
  • Asakura K; JEOL Ltd.
  • Suematsu T; JEOL RESONANCE Inc.
  • Muto H; JEOL RESONANCE Inc.
  • Kohama A; Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ).
  • Goto T; Nippon Shinyaku Co., Ltd.
  • Yasuda M; Nippon Shinyaku Co., Ltd.
  • Ueda T; Sumitomo Pharma Co., Ltd.
  • Goda Y; National Institute of Health Sciences (NIHS).
Chem Pharm Bull (Tokyo) ; 70(12): 892-900, 2022 Dec 01.
Article em En | MEDLINE | ID: mdl-36223954
Quantitative 1H-NMR (1H-qNMR) is useful for determining the absolute purity of organic molecules; however, it is sometimes difficult to identify the target signal(s) for quantitation because of their overlap and complexity. Therefore, we focused on the 31P nucleus because of the simplicity of its signals and previously reported 31P-qNMR in D2O. Here we report 31P-qNMR of an organophosphorus compound, sofosbuvir (SOF), which is soluble in organic solvents. Phosphonoacetic acid (PAA) and 1,4-bis(trimethylsilyl)benzene-d4 (1,4-BTMSB-d4) were used as reference standards for 31P-qNMR and 1H-qNMR, respectively, in methanol-d4. The purity of SOF determined by 31P-qNMR was 100.63 ± 0.95%, whereas that determined by 1H-qNMR was 99.07 ± 0.50%. The average half bandwidths of the 31P signal of PAA and SOF were 3.38 ± 2.39 and 2.22 ± 0.19 Hz, respectively, suggesting that the T2 relaxation time of the PAA signal was shorter than that of SOF and varied among test laboratories. This difference most likely arose from the instability in the chemical shift due to the deuterium exchange of the acidic protons of PAA, which decreased the integrated intensity of the PAA signal. Next, an aprotic solvent, dimethyl sulfoxide-d6 (DMSO-d6), was used as the dissolving solvent with PAA and sodium 4,4-dimethyl-4-silapentanesulfonate-d6 (DSS-d6) as reference standards for 31P-qNMR and 1H-qNMR, respectively. SOF purities determined by 31P-qNMR and 1H-qNMR were 99.10 ± 0.30 and 99.44 ± 0.29%, respectively. SOF purities determined by 31P-qNMR agreed with the established 1H-qNMR values, suggesting that an aprotic solvent is preferable for 31P-qNMR because it is unnecessary to consider the effect of deuterium exchange.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article